Dominic King-Smith
President and CEO @Enzen Therapeutics, Inc
Signup · Get unlimited contacts
WORK HISTORY
President and CEO @Enzen Therapeutics, Inc
San Diego, CA, US
EnZen Therapeutics is developing Innovative therapies for Diseases of Epithelial Barrier Impairment (termed DEBIs). EnZen’s mission is to provide effective treatments for many millions of DEBI sufferers based on a novel therapeutic agent delivered directly to the affected epithelial tissue.
EDUCATION
University of Cambridge
Bachelor’s Degree, Physics and Theoretical Physics
University of Cambridge
Junior Research Fellow St. John's College, Theoretical and Computational Physics
University of Cambridge
Ph.D., Theoretical Physics
Rutgers University
Postdoctoral Research Fellow, Theoretical and Computational Physics
ABOUT DOMINIC KING-SMITH
Life sciences executive and entrepreneur with repeated successes in building enterprise value over a 20-year career Couples deep strategic thinking, leadership, operational excellence, company formation abilities, financing experience, proven corporate and business development skills with outstanding technical and scientific accomplishments Track record of achievements in pharmaceutical development and commercialization, drug delivery, high throughput experimentation, and computational chemistry Substantial international experience, in both Europe and Asia, in addition to domestic accomplishments Deep understanding of intellectual property strategy and its critical integration into corporate strategy Inventor on multiple FDA Orange Book listed patentsI enjoy meeting new people and understanding new perspectives. Reach out if you want to talk to me about emerging life sciences technologies or drug development.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.